ZZEF1 inhibitors represent a class of compounds that target the ZZ-type zinc finger and EF-hand domain-containing protein 1 (ZZEF1). This protein is a multi-domain molecule containing both zinc finger motifs and EF-hand calcium-binding domains, which are often associated with a variety of regulatory functions within cellular processes. Zinc finger domains are known to facilitate protein-DNA and protein-protein interactions, making them crucial for transcriptional regulation and cellular signaling pathways. The EF-hand domains, on the other hand, provide calcium-binding capability, which plays a role in mediating various calcium-dependent processes such as signal transduction, gene expression, and cytoskeletal organization. ZZEF1 is therefore implicated in multiple cellular pathways that involve the coordination of both DNA interaction and calcium signaling.
Inhibitors targeting ZZEF1 typically function by interfering with the protein's ability to bind either to its specific DNA targets or its protein partners, or by altering its calcium-binding activity. By obstructing these interactions, ZZEF1 inhibitors can modulate key cellular processes such as transcription, gene expression regulation, and signal transduction. The precise mode of action of these inhibitors varies depending on their chemical structure and their binding affinity to the different domains of ZZEF1. In general, the design of such inhibitors often focuses on their ability to disrupt the zinc finger or EF-hand domains individually, though some compounds might exhibit multi-domain inhibitory effects. Structural biology techniques like X-ray crystallography and NMR spectroscopy are often employed to study the binding interactions of ZZEF1 inhibitors, shedding light on their mechanistic action at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An inhibitor of histone deacetylases (HDAC) that can alter chromatin structure, potentially affecting ZZEF1's ability to bind to DNA or modify its transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter DNA methylation patterns, potentially influencing ZZEF1's interaction with methylated DNA regions. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
An MDM2 antagonist that stabilizes p53, which can alter the transcription of genes, including potentially those regulated by ZZEF1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can prevent the degradation of proteins, potentially increasing the levels of proteins that regulate or interact with ZZEF1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK) that can affect transcription factor activity, potentially modulating ZZEF1's role in gene expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
An inhibitor of phosphatidylinositol 3-kinase (PI3K) that can affect multiple signaling pathways, potentially altering the functional state of ZZEF1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor that can affect stress-activated pathways and cytokine production, potentially influencing ZZEF1's cellular responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
An inhibitor of MEK1/2 that can prevent ERK activation, potentially modulating the activity or expression of ZZEF1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor that can disrupt actin cytoskeleton organization, potentially influencing ZZEF1's interactions with cytoskeletal elements. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A specific inhibitor of MEK that can block the MAPK/ERK pathway, potentially affecting ZZEF1's role in signaling or regulatory pathways. | ||||||